Literature DB >> 3869422

Diabetes and coronary heart disease.

K Pyörälä.   

Abstract

Clinically manifest coronary heart disease (CHD) is not uncommon in diabetics with insulin-dependent type of the disease below the age of 40, particularly when the duration of diabetes is long. Clinically manifest CHD is very common in diabetics with maturity-onset, non-insulin-dependent type of the disease, and in this type of diabetes the frequency of CHD shows little or no relation to the duration of diabetes. Premenopausal female diabetics have a clinically manifest CHD almost as often as male diabetics of the same age--a situation in sharp contrast to that in non-diabetics with large excess of CHD in males. The incidence of all manifestations of CHD (sudden and nonsudden CHD death, non-fatal myocardial infarction, "silent" myocardial infarction, and angina pectoris) is increased in diabetics as compared to non-diabetics, but the excess of CHD mortality in diabetics is especially marked, being 3 to 4 times higher than in non-diabetics. The incidence of congestive heart failure is markedly increased in diabetics and this is in part independent of increased occurrence of CHD and hypertension among diabetics. Subclinical abnormalities of left ventricular function are common in diabetics and these abnormalities appear to show some relationship to the metabolic control of diabetes and in insulin-dependent diabetics also to the presence of microangiopathy. Diabetes is associated with changes in general CHD risk factors to atherogenic direction. These changes include abnormalities in the levels and composition of plasma lipids and lipoproteins and increased frequency of hypertension. The impact of general risk factors on CHD risk appears to be similar in diabetics and non-diabetics.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 3869422

Source DB:  PubMed          Journal:  Acta Endocrinol Suppl (Copenh)        ISSN: 0300-9750


  6 in total

1.  Asymptomatic coronary artery disease in diabetes: associated with autonomic neuropathy?

Authors:  M J Koistinen; K E Airaksinen; H V Huikuri; H Pirttiaho; M K Linnaluoto; M J Ikäheimo; J T Takkunen
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

2.  Diabetes-induced changes in the contractility of the aorta and pA2 of nifedipine in the rat.

Authors:  M Mahmoudian; F Behnaz; E Rezaei
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

Review 3.  Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  G Panzram
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

4.  Diabetic cardiomyopathy and reactive oxygen species (ROS) related parameters in male and female rats: A comparative study.

Authors:  Vidya Akhileshwar; Samir P Patel; Surendra S Katyare
Journal:  Indian J Clin Biochem       Date:  2007-03

5.  Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-09-07       Impact factor: 9.951

6.  Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2.

Authors:  Thomas W Jax; Ansgar J Peters; Gunnar Plehn; Frank-Chris Schoebel
Journal:  Cardiovasc Diabetol       Date:  2009-05-06       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.